Literature DB >> 15467530

A practical approach to the diagnosis of polycystic ovary syndrome.

R Jeffrey Chang1.   

Abstract

The diagnosis of polycystic ovary syndrome (PCOS) is primarily achieved through clinical history and physical findings. The principle features are hirsutism or biochemical evidence of excess androgen production and irregular menstrual bleeding caused by the chronic anovulation. Associated findings include insulin resistance with compensatory hyperinsulinemia and obesity. Ultrasound imaging of the ovary has facilitated the diagnosis. It is important to exclude conditions that may mimic PCOS, such as hyperthecosis, congenital adrenal hyperplasia, 21-hydroxylase deficiency, Cushing's syndrome, and androgen-producing neoplasms. These disorders are usually revealed by appropriate laboratory assessment. Screening tests include measurement of serum total testosterone, DHEA sulfate, and 17-hydroxyprogesterone. In addition, in the obese individual, determinations of glucose and insulin levels, as well as a lipid profile, are highly recommended.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15467530     DOI: 10.1016/j.ajog.2004.04.045

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  15 in total

1.  The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients.

Authors:  J R Palacio; A Iborra; Z Ulcova-Gallova; R Badia; P Martínez
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  The effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study.

Authors:  Sedigheh Ghandi; Abbas Aflatoonian; Nasim Tabibnejad; Mohammad Hossein Sojoodi Moghaddam
Journal:  J Assist Reprod Genet       Date:  2011-04-12       Impact factor: 3.412

3.  Differential Contributions of Polycystic Ovary Syndrome (PCOS) Manifestations to Psychological Symptoms.

Authors:  Judy G McCook; Beth A Bailey; Stacey L Williams; Sheeba Anand; Nancy E Reame
Journal:  J Behav Health Serv Res       Date:  2015-07       Impact factor: 1.505

4.  Methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish patients with polycystic ovary syndrome.

Authors:  Muammer Karadeniz; Mehmet Erdogan; Ayhan Zengi; Zuhal Eroglu; Sadik Tamsel; Murat Olukman; Fusun Saygili; Candeger Yilmaz
Journal:  Endocrine       Date:  2010-07-09       Impact factor: 3.633

5.  Apolipoprotein E gene polymorphism and polycystic ovary syndrome patients in Western Anatolia, Turkey.

Authors:  Sevki Cetinkalp; Muammer Karadeniz; Mehmet Erdogan; Ayhan Zengi; Vildan Cetintas; Asli Tetik; Zuhal Eroglu; Buket Kosova; A Gokhan Ozgen; Fusun Saygili; Candeger Yilmaz
Journal:  J Assist Reprod Genet       Date:  2008-12-05       Impact factor: 3.412

6.  4G/5G polymorphism of PAI-1 gene and Alu-repeat I/D polymorphism of TPA gene in Turkish patients with polycystic ovary syndrome.

Authors:  Muammer Karadeniz; Mehmet Erdogan; Afig Berdeli; Fusun Saygili; Candeger Yilmaz
Journal:  J Assist Reprod Genet       Date:  2007-07-28       Impact factor: 3.412

7.  Metformin therapy in a hyperandrogenic anovulatory mutant murine model with polycystic ovarian syndrome characteristics improves oocyte maturity during superovulation.

Authors:  Mary E Sabatini; Lankai Guo; Maureen P Lynch; Joseph O Doyle; Hojoon Lee; Bo R Rueda; Aaron K Styer
Journal:  J Ovarian Res       Date:  2011-05-23       Impact factor: 4.234

8.  Effect Of G2706A and G1051A polymorphisms of the ABCA1 gene on the lipid, oxidative stress and homocystein levels in Turkish patients with polycystıc ovary syndrome.

Authors:  Muammer Karadeniz; Mehmet Erdoğan; Zengi Ayhan; Murat Yalcin; Murat Olukman; Sevki Cetinkalp; Gulinnaz E Alper; Zuhal Eroglu; Asli Tetik; Vildan Cetintas; Ahmet G Ozgen; Fusun Saygili; Candeger Yilmaz
Journal:  Lipids Health Dis       Date:  2011-10-28       Impact factor: 3.876

9.  Stimulatory effect of morning bright light on reproductive hormones and ovulation: results of a controlled crossover trial.

Authors:  Konstantin V Danilenko; Elena A Samoilova
Journal:  PLoS Clin Trials       Date:  2007-02-09

10.  The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS).

Authors:  Aylin Yaba; Necdet Demir
Journal:  J Ovarian Res       Date:  2012-11-27       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.